This legislation requires the Secretary of Veterans Affairs to submit a comprehensive report to Congress within one year of enactment. This report, developed in consultation with the Director of the Centers for Disease Control and Prevention, must detail the incidence and prevalence of amyotrophic lateral sclerosis (ALS) among veterans. The report will also include a description of existing resources and support provided by the CDC and VA for veterans with ALS, along with an identification of any deficiencies in these services. Furthermore, it mandates the development of strategies for risk reduction to lower ALS rates and a pathway for veterans to participate in VA-sponsored clinical trials and research . Finally, the bill requires the VA Secretary to continuously track ALS prevalence in veterans using the CDC's registry and biorepository, with updated reports to be submitted to Congress every three years.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Veterans' Affairs.
Referred to the Subcommittee on Health.
Subcommittee Hearings Held
Introduced in House
Referred to the House Committee on Veterans' Affairs.
Referred to the Subcommittee on Health.
Subcommittee Hearings Held
Armed Forces and National Security
Congressional oversightGovernment information and archivesHealth information and medical recordsNeurological disordersVeterans' medical care
Veterans with ALS Reporting Act
USA119th CongressHR-6001| House
| Updated: 1/13/2026
This legislation requires the Secretary of Veterans Affairs to submit a comprehensive report to Congress within one year of enactment. This report, developed in consultation with the Director of the Centers for Disease Control and Prevention, must detail the incidence and prevalence of amyotrophic lateral sclerosis (ALS) among veterans. The report will also include a description of existing resources and support provided by the CDC and VA for veterans with ALS, along with an identification of any deficiencies in these services. Furthermore, it mandates the development of strategies for risk reduction to lower ALS rates and a pathway for veterans to participate in VA-sponsored clinical trials and research . Finally, the bill requires the VA Secretary to continuously track ALS prevalence in veterans using the CDC's registry and biorepository, with updated reports to be submitted to Congress every three years.